1. Home
  2. NKX vs OABI Comparison

NKX vs OABI Comparison

Compare NKX & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen California AMT-Free Quality Municipal Income Fund

NKX

Nuveen California AMT-Free Quality Municipal Income Fund

HOLD

Current Price

$10.85

Market Cap

640.3M

Sector

Finance

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$4.75

Market Cap

696.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKX
OABI
Founded
2002
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
640.3M
696.4M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
NKX
OABI
Price
$10.85
$4.75
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $8.33
AVG Volume (30 Days)
412.1K
★ 1.3M
Earning Date
01-01-0001
10-30-2026
Dividend Yield
★ 4.37%
N/A
EPS Growth
N/A
★ 6.56
EPS
★ N/A
N/A
Revenue
N/A
★ $18,666,000.00
Revenue This Year
N/A
$87.73
Revenue Next Year
N/A
$25.31
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$10.30
$1.32
52 Week High
$13.20
$5.43

Technical Indicators

Market Signals
Indicator
NKX
OABI
Relative Strength Index (RSI) 49.39 52.65
Support Level $10.30 $1.93
Resistance Level $12.59 $5.06
Average True Range (ATR) 0.21 0.35
MACD 0.09 -0.02
Stochastic Oscillator 54.50 55.60

Price Performance

Historical Comparison
NKX
OABI

About NKX Nuveen California AMT-Free Quality Municipal Income Fund

Nuveen California AMT-Free Quality Municipal Income Fund is a closed-end fixed income mutual fund. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. It invests across sectors such as healthcare, utilities, transportation, and housing.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: